BR9916417A - Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma - Google Patents
Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasmaInfo
- Publication number
- BR9916417A BR9916417A BR9916417-5A BR9916417A BR9916417A BR 9916417 A BR9916417 A BR 9916417A BR 9916417 A BR9916417 A BR 9916417A BR 9916417 A BR9916417 A BR 9916417A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- sarcosystis
- neospora
- toxoplasma
- compounds
- Prior art date
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 4
- 201000010099 disease Diseases 0.000 title abstract 3
- 241001147660 Neospora Species 0.000 title abstract 2
- 241000223996 Toxoplasma Species 0.000 title abstract 2
- QMNWYGTWTXOQTP-UHFFFAOYSA-N 1h-triazin-6-one Chemical class O=C1C=CN=NN1 QMNWYGTWTXOQTP-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 201000005485 Toxoplasmosis Diseases 0.000 abstract 1
- 206010000210 abortion Diseases 0.000 abstract 1
- 231100000176 abortion Toxicity 0.000 abstract 1
- 230000002036 metaphylactic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000926 neurological effect Effects 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21871298A | 1998-12-22 | 1998-12-22 | |
| PCT/US1999/030284 WO2000037084A1 (en) | 1998-12-22 | 1999-12-17 | Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9916417A true BR9916417A (pt) | 2001-11-06 |
Family
ID=22816194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9916417-5A BR9916417A (pt) | 1998-12-22 | 1999-12-17 | Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1140101A1 (zh) |
| JP (1) | JP2002532552A (zh) |
| KR (1) | KR20010080571A (zh) |
| CN (1) | CN1331595A (zh) |
| AU (1) | AU2198100A (zh) |
| BR (1) | BR9916417A (zh) |
| CA (1) | CA2356181A1 (zh) |
| HK (1) | HK1043065A1 (zh) |
| HU (1) | HUP0104716A3 (zh) |
| NZ (1) | NZ512476A (zh) |
| WO (1) | WO2000037084A1 (zh) |
| ZA (1) | ZA200103919B (zh) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1189175C (zh) | 1998-10-08 | 2005-02-16 | 高新研究公司 | 用于预防和治疗原虫病的组合物和方法 |
| DE19958388A1 (de) * | 1999-12-03 | 2001-06-07 | Bayer Ag | Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten |
| DE10040174A1 (de) * | 2000-08-17 | 2002-02-28 | Bayer Ag | Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen |
| DE10040110A1 (de) * | 2000-08-17 | 2002-02-28 | Bayer Ag | Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen |
| DE102007025908A1 (de) * | 2007-06-01 | 2008-12-04 | Bayer Healthcare Ag | Formulierungen enthaltend Triazinone und Eisen |
| DE102009012423A1 (de) * | 2009-03-10 | 2010-09-16 | Bayer Animal Health Gmbh | Zubereitung auf Ölbasis |
| CN102973497A (zh) * | 2012-12-13 | 2013-03-20 | 江苏恒丰强生物技术有限公司 | 一种托曲珠利溶液及其制备方法 |
| MX2020008816A (es) | 2018-02-26 | 2020-09-28 | AlzeCure Pharma AB | Derivados de triazina para el tratamiento de enfermedades relacionadas con neurotrofinas. |
| GB201810668D0 (en) | 2018-06-28 | 2018-08-15 | Stiftelsen Alzecure | New compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9808114A (pt) * | 1997-03-31 | 2000-03-08 | David Granstrom | Formulação de ração para cavalos utilizável para tratar epm, processos para tratar pm em um cavalo que necessita deste tratamento, para prevenir infecção com s. neutrona em cavalos, e, para exterminar s. neurona em cavalos |
-
1999
- 1999-12-17 AU AU21981/00A patent/AU2198100A/en not_active Abandoned
- 1999-12-17 HU HU0104716A patent/HUP0104716A3/hu unknown
- 1999-12-17 NZ NZ512476A patent/NZ512476A/en unknown
- 1999-12-17 CA CA002356181A patent/CA2356181A1/en not_active Abandoned
- 1999-12-17 JP JP2000589195A patent/JP2002532552A/ja active Pending
- 1999-12-17 EP EP99966449A patent/EP1140101A1/en not_active Withdrawn
- 1999-12-17 KR KR1020017006550A patent/KR20010080571A/ko not_active Application Discontinuation
- 1999-12-17 BR BR9916417-5A patent/BR9916417A/pt not_active IP Right Cessation
- 1999-12-17 CN CN99815013A patent/CN1331595A/zh active Pending
- 1999-12-17 WO PCT/US1999/030284 patent/WO2000037084A1/en not_active Application Discontinuation
-
2001
- 2001-05-15 ZA ZA200103919A patent/ZA200103919B/en unknown
-
2002
- 2002-07-05 HK HK02105041.6A patent/HK1043065A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2356181A1 (en) | 2000-06-29 |
| HUP0104716A2 (hu) | 2002-04-29 |
| KR20010080571A (ko) | 2001-08-22 |
| JP2002532552A (ja) | 2002-10-02 |
| CN1331595A (zh) | 2002-01-16 |
| ZA200103919B (en) | 2002-05-15 |
| NZ512476A (en) | 2003-08-29 |
| WO2000037084A1 (en) | 2000-06-29 |
| HK1043065A1 (zh) | 2002-09-06 |
| HUP0104716A3 (en) | 2003-10-28 |
| EP1140101A1 (en) | 2001-10-10 |
| AU2198100A (en) | 2000-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE2018C038I2 (zh) | ||
| AP2004003069A0 (en) | 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof. | |
| ATE334668T1 (de) | Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen | |
| BR0317747A (pt) | Método de tratamento terapêutico concomitante de um indivìduo, composição farmacêutica, kit, uso de um primeiro agente e um segundo agente, e, métodos de prevenir ou tratar uma doença relacionada com amilóide-b, doença de alzheimer e insuficiência cognitiva suave | |
| RU94045155A (ru) | Способы ингибирования болезни альцгеймера | |
| BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
| DE60036456D1 (de) | Antimikrobiell wirksames oder endotoxin neutralisierendes polypeptid | |
| ATE496048T1 (de) | Phenylcarboxamidverbindungen zur schmerzbehandlung | |
| BR9911094A (pt) | Composições e métodos para o tratamento detosse | |
| PT1140102E (pt) | Compostos de triazinona para tratar doencas causadas por sarcosystis, neospora etoxoplasma | |
| BR9916417A (pt) | Compostos triazinaona para tratamento de doenças devidas à sarcosystis, neospora e toxoplasma | |
| BR9604973A (pt) | Uma composição farmacêutica contendo carbamatos de n-cloro fenila e tiocarbamatos de n-cloro fenila para inibição de crescimento de vírus e cânceres | |
| BR9916391A (pt) | Compostos de triazineona para o tratamento de doenças causadas por sarcosiste, neopora e toxoplasma | |
| BR9815070A (pt) | Compostos tendo efeito inibitório da cgmp-pde | |
| BR0210401A (pt) | Composto, composição farmacêutica, uso de um composto e método para o tratamento de um distúrbio ou de uma doença de um corpo de animal vivo, incluindo um humano | |
| BR9808263A (pt) | Processos para tratar câncer em um humano em necessidade de tratamento e para manufaturar um medicamento para inibir o crescimento em um humano de um tumor sólido, e, uso de um composto. | |
| HUP0000110A2 (hu) | Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények | |
| BR0015781A (pt) | Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea | |
| YU60199A (sh) | Nove soli bpc peptida sa organo-zaštitnom aktivnošću, postupak za njihovo dobijanje i njihova primena u terapiji | |
| BR0308911A (pt) | Composto, composição farmacêutica, métodos de tratamento de dor e de enxaqueca, e, uso de um composto | |
| HUP0302330A2 (hu) | Praziquanteltartalmú készítmények sarcocystis, neospora, toxoplasma és isospora által okozott betegségek kezelésére | |
| BR0210407A (pt) | Composto, composição farmacêutica, uso de um composto e método de tratamento de um distúrbio ou de uma doença de corpo animal vivo, incluindo um humano | |
| SI0872239T1 (en) | Use of olanzapine for the manufacture of a medicament for the treatment of cerebral focal ischemia | |
| BR0002260A (pt) | Métodos e composições para o tratamento de distúrbios relacionados com a idade, em animais de companhia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6O E 7O ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |